Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.59 +0.10 (+1.05%)
At close: Nov 11, 2026 · 4:00 PM EST

Syndax Pharmaceuticals (SNDX) Return on Equity [ROE] (2016 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Return on Equity [ROE] of -625.06% in Q2 2026, down 456.85 percentage points from -168.21% a year earlier and down 240.26 percentage points from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For FY2025, Syndax Pharmaceuticals reported Return on Equity [ROE] of -141.95%, down 67.49 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for four straight years, with a five-year change of -90.54 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -74.46% in FY2024 (-33.54 pp), -40.91% in FY2023 (-6.88 pp), -34.03% in FY2022 (-41.52 pp) and 7.49% in FY2021 (+58.89 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q2 2016.
  • On a year-over-year basis, Return on Equity [ROE] has declined for 15 consecutive quarters, with an average year-over-year change of -162.39 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 46.11 percentage points in Q4 2021, against a drop of 456.85 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -384.79% (Q1 2026), -278.09% (Q4 2025) and -206.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -654.39%
Mar 31, 2026 -400.45%
Dec 31, 2025 -287.32%
Sep 30, 2025 -212.27%
Jun 30, 2025 -167.55%
Mar 31, 2025 -125.91%
Dec 31, 2024 -95.81%
Sep 30, 2024 -74.14%
Jun 30, 2024 -57.21%
Mar 31, 2024 -46.21%
Dec 31, 2023 -45.75%
Sep 30, 2023 -46.26%
Jun 30, 2023 -38.36%
Mar 31, 2023 -34.04%
Dec 31, 2022 -37.46%
Sep 30, 2022 -4.56%
Jun 30, 2022 -0.25%
Mar 31, 2022 3.69%
Dec 31, 2021 8.10%
Sep 30, 2021 -44.32%
API Access

Syndax Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SNDX&period=max&api_key=YOUR_API_KEY